Europe — EMA
Oxbryta (Voxelotor)
Voxelotor, the active ingredient in Oxbryta, is a unknown presented as a / for oral use. It treats sickle cell disease in adults and children.
Request sourcing
1
Pack/s
What is Voxelotor?
Voxelotor, the active ingredient in Oxbryta, is a unknown presented as a / for oral use. It treats sickle cell disease in adults and children.
GNH USA supplies Oxbryta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Voxelotor used for?
Oxbryta is an oral receptor but the g ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...
What are the side effects of Voxelotor?
Common
What precautions apply to Voxelotor?
...
Product details
Drug
Voxelotor
Route
Oral Use
Manufacturer
Pfizer Europe Ma Eeig
Origin
EU
